Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
A Treatment Study Protocol for Participants 1-45 Years With Acute Lymphoblastic Leukaemia

ALLTogether collects the experience of previously successful treatment of children and young adults, with ALL from a number of well-renowned study groups into a new master protocol, which is both a comprehensive system for stratification and treatment of ALL in this age-group as well as the basis for several randomised …

dexamethasone
vincristine
imatinib
doxorubicin
inotuzumab
  • 27 views
  • 27 Jan, 2021
  • 102 locations
Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)

diagnosed acute myeloid leukemia (AML) patients displaying a cytogenetic aberration or fusion transcript in the core-binding factor (CBF) genes or FMS-like tyrosine Kinase 3 (FLT3) mutation.

tyrosine
hydroxyurea
daunorubicin
gemtuzumab
cytarabine
  • 12 views
  • 08 Mar, 2021
  • 11 locations
Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

)] with evidence of: - t(5;12)(q33;p13) by cytogenetic or fluorescent in situ hybridization (FISH) analysis, or - ETV6/TEL-PDGFRB fusion transcript by reverse

myelodysplastic/myeloproliferative neoplasm
bone marrow transplant
leukemia
chronic myelomonocytic leukemia
bone marrow procedure
  • 10 views
  • 07 Nov, 2020
  • 14 locations
ABL001 for the Treatment of Chronic Myeloid Leukemia in Patients Who Are on Therapy With Tyrosine Kinase Inhibitor

This phase II trial studies how well ABL001 works in treating patients with chronic myeloid leukemia who are on therapy with tyrosine kinase inhibitor. ABL001 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving ABL001 and tyrosine kinase inhibitor together may …

  • 0 views
  • 26 Jan, 2021